NHS National Framework Supply Agreement for Tenofovir Alafenamide/Emtricitabine 200/10mg and 200/25mg Tablets

This is a national framework supply agreement for Tenofovir alafenamide/Emtricitabine (TAF/FTC) antiretroviral medication in two strengths: 200/10mg and 200/25mg tablets. The framework is divided into three geographic lots: Lot 1 covers London North West, Lot 2 covers Durham North East and South of England, and Lot 3 covers Durham North West and Midlands. The initial agreement period runs from 1 February 2027 to 31 October 2028 (21 months), with the option to extend for up to an additional 24 months at the discretion of NHS England. This procurement is managed by NHS Medicines Value & Access on behalf of NHS England. Suppliers should note the reference number CM/TNS/26/5744 for all inquiries and submissions.